LCM
RMD icon

Laurion Capital Management’s ResMed RMD Stock Holding History

Laurion Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,744
Closed -$1.1M – 549
2024
Q2 		$1.1M Buy
+5,744
New +$1.17M 0.01% 279
2021
Q3 		– Sell
-833
Closed -$205K – 843
2021
Q2 		$205K Buy
+833
New +$175K ﹤0.01% 642
2017
Q1 		– Sell
-7,300
Closed -$453K – 1533
2016
Q4 		$453K Buy
+7,300
New +$447K ﹤0.01% 858
2016
Q1 		– Sell
-6,600
Closed -$354K – 1055
2015
Q4 		$354K Buy
+6,600
New +$372K ﹤0.01% 579

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Laurion Capital Management's RMD Position: Q3 2024 in Review

Laurion Capital Management sold out of ResMed (RMD) in Q3 2024, closing a stake of 5,744 shares — an estimated $1.1M sold.

Laurion Capital Management first reported a position in RMD in Q4 2015 and held it in 4 quarters. The position peaked at $1.1M in Q2 2024. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Laurion Capital Management reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • Laurion Capital Management sold 5,744 ResMed shares in Q3 2024, an estimated $1.1M.
  • Laurion Capital Management first reported a position in ResMed in Q4 2015 and held it in 4 quarters.
  • Laurion Capital Management's ResMed position peaked at $1.1M in Q2 2024.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.